Study Design
Well-designed clinical trials are essential to successful clinical development. Many compounds do not reach market because of flaws in the design stage. To optimize your study, you need a partner who will help you plan the course of your clinical trial, proactively improve predictability, reduce risks and help you reach Go/No-Go decisions faster. Our experienced biostatistician will partner with you to provide the optimal clinical trial design, looking for efficacy signals to achieve better outcomes for the resources spent. This includes developing the synopsis and the full protocol document, calculating the sample size for conventional, group-sequential or adaptive designs (including Bayesian designs), running trial simulations, and proposing innovative solutions to expedite and optimize chances of success of your clinical trial.
Study Design Services include:
Selection of the patient population;
- Choice of efficient and reliable endpoints, as well as validation of surrogate endpoints
- Sample size calculation
- Sample size re-assessment during the study (blinded or unblinded using DMC)
- Trial simulations
- Adaptive trial set-up
- Factorial and cross-over designs for selected situations
- Randomization
- Statistical analysis using of state-of-the-art and novel methods
- Interim analysis
- Experience in assisting clients in dealing with regulatory authorities, including the FDA and EMA, to discuss the study design or to defend the study results